news Archives - Page 43 of 100 - Journal for Clinical Studies

Current Edition

Europe

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Immunotherapy with nivolumab and low-dose ipilimumab could become a new first line treatment in patients with some metastatic colorectal cancers following late-breaki...

25 October 2018 Europe | news | North America | Regional News

Continue Reading →

news

FDA approves asthma indication for Dupixent® (dupilumab)

Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic approved for oral corticosteroid-dependent asthma, ...

25 October 2018 news | North America | Regional News

Continue Reading →

Europe

Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

Groningen, The Netherlands, October 22, 2018 / B3C newswire / -- Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable ...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Genmab Announces Positive Topline Results in Phase III CASSIOPEIA Study of Daratumumab in Front Line Multiple Myeloma

Phase III CASSIOPEIA study of daratumumab in combination with bortezomib, thalidomide and dexamethasone in front line multiple myeloma met the primary endpoint of ...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Nanobiotix: Positive Phase II / III Results for NBTXR3 in Soft Tissue Sarcoma Presented at ESMO

Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie - Paris, presented first-in-class NBTXR3 positive Phase II/III results during...

25 October 2018 Europe | news | North America | Regional News

Continue Reading →

news

Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer – The primary endpoint was met

Orion and Bayer have completed the phase III clinical trial (ARAMIS) of darolutamide, the novel oral androgen receptor antagonist for the treatment of patients with n...

25 October 2018 news | North America

Continue Reading →

Europe

Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including overall survival

Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including o...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec Nanomedicine Drug Candidate in Ovarian Cancer

Maastricht, The Netherlands, October 25, 2018 / B3C newswire / -- Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for th...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the Return of investigational drug products used in Clinical studi...

22 October 2018 Europe | news | Regional News

Continue Reading →

news

PCI Pharma Services Completes Acquisition of Sherpa Clinical Packaging

PCI continues expansion of its global clinical services network to California. Philadelphia, USA – October 2, 2018 Leading global biopharmaceutical outsourcing servic...

22 October 2018 news | North America | Regional News

Continue Reading →